VYNE Therapeutics
VYNE
#9889
Rank
NZ$42.39 M
Marketcap
$2.79
Share price
-6.59%
Change (1 day)
-40.76%
Change (1 year)

EPS for VYNE Therapeutics (VYNE)

EPS in 2023 (TTM): -$18.13

According to VYNE Therapeutics's latest financial reports the company's current EPS (TTM) is -$19.73. In 2022 the company made an earnings per share (EPS) of -$13.10 an increase over its 2021 EPS that were of -$46.31.

EPS history for VYNE Therapeutics from 2017 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$18.1338.43%
2022-$13.10-71.72%
2021-$46.31-84.19%
2020-$292.98-26.29%
2019-$397.5128.75%
2018-$308.7410.79%
2017-$278.67

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.90-80.25%๐Ÿ‡บ๐Ÿ‡ธ USA